Male Pseudohermaphroditism due to 17β-Hydroxysteroid Dehydrogenase 3 Deficiency: Diagnosis, Psychological Evaluation, and Management

Berenice B. Mendonça(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Jean D. Wilson(The University of Texas Southwestern Medical Center), Frederico A.Q. Silva(Universidade de São Paulo), Elaine Maria Frade Costa(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), W Bloise, Francisco Tibor Dénes(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Ivo J.P. Arnhold(Associação Paulista para o Desenvolvimento da Medicina), Annika Lindqvist(The University of Texas Southwestern Medical Center), Marlene Inácio(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Stefan Andersson(Uppsala University), Regina Matsunaga Martin(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo)
Medicine
September 1, 2000
10.1097/00005792-200009000-00003
Cited by 139

Related Papers

STEROID 5α-REDUCTASE: TWO GENES/TWO ENZYMES
|Annual Review of Biochemistry|1994|1.1k
Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
|Nature|1991|644
Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3
|Nature Genetics|1994|574
A <i>GPR54</i> -Activating Mutation in a Patient with Central Precocious Puberty
|New England Journal of Medicine|2008|566
Central Precocious Puberty Caused by Mutations in the Imprinted Gene <i>MKRN3</i>
|New England Journal of Medicine|2013|524